Verition Fund Management’s Cano Health, Inc. CANO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-6,082
Closed -$845K 2778
2023
Q2
$845K Sell
6,082
-7,127
-54% -$915K 0.01% 990
2023
Q1
$1.2M Buy
13,209
+2,630
+25% +$357K 0.02% 880
2022
Q4
$1.45M Buy
10,579
+8,643
+446% +$2.93M 0.02% 759
2022
Q3
$1.68M Buy
1,936
+744
+62% +$466K 0.02% 1033
2022
Q2
$522K Buy
1,192
+1,026
+618% +$535K 0.01% 1423
2022
Q1
$105K Sell
166
-59
-26% -$37.2K ﹤0.01% 2425
2021
Q4
$200K Buy
+225
New +$236K ﹤0.01% 2249
2020
Q4
Sell
-2,359
Closed -$2.46M 1453
2020
Q3
$2.46M Buy
+2,359
New +$2.47M 0.05% 213

Other funds holding CANO

Verition Fund Management's CANO Position: Q3 2023 in Review

Verition Fund Management sold out of Cano Health, Inc. (CANO) in Q3 2023, closing a stake of 6,082 shares — an estimated $845K sold.

Verition Fund Management first reported a position in CANO in Q3 2020 and held it in 8 quarters. The position peaked at $2.46M in Q3 2020. 134 funds tracked by Wall St. Rank hold CANO as of Q3 2023.

  • Verition Fund Management reported no remaining Cano Health, Inc. position as of Q3 2023 after selling out during the quarter.
  • Verition Fund Management sold 6,082 Cano Health, Inc. shares in Q3 2023, an estimated $845K.
  • Verition Fund Management first reported a position in Cano Health, Inc. in Q3 2020 and held it in 8 quarters.
  • Verition Fund Management's Cano Health, Inc. position peaked at $2.46M in Q3 2020.
  • 134 funds tracked by Wall St. Rank held Cano Health, Inc. as of Q3 2023.

Based on Verition Fund Management's 13F filing for Q3 2023, filed 14 Nov 2023.